The domestic sales team of Gedian Humanwell covers 30 provinces in China, while the export business has covered many countries and regions in Europe, North America, South America, Southeast Asia, Middle East and Africa as well as Australia etc.
Active Pharmaceutical Ingredients
Progestogen and Estrogen | |||
Product Name | Specification | Approved | CAS No. |
Progesterone | CP/EP/USP | CEP/EU-GMP/FDA | 57-83-0 |
Pregnenolone |
In-house |
Kosher | 145-13-1 |
Medroxyprogesterone Acetate | CP/EP/USP | DMF/GMP | 71-58-9 |
Megestrol Acetate | CP/EP/USP | DMF in process | 595-33-5 |
Mifepristone | CP/IP | DMF/GMP | 84371-65-3 |
Cyproterone Acetate | CP/EP | CEP/TGA/GMP | 427-51-0 |
Levonorgestrel | CP/EP/USP | DMF/GMP/CEP | 797-63-7 |
Drospirenone | EP/USP | DMF | 67392-87-4 |
Gestodene | CP/EP | DMF/GMP | 60282-87-3 |
Estradiol | CP/EP/USP | DMF | 50-28-2 |
Estriol | CP/EP/USP | Under R&D | 50-27- 1 |
Ethinyl Estradiol | CP/EP/USP | DMF/GMP | 57-63-6 |
Estradiol Valerate | CP | DMF in process | 979-32-8 |
Tibolone | CP/EP | DMF | 5630-53-5 |
Dienogest | EP | DMF | 65928-58-7 |
Fulvestrant | In-house | Under R&D | 129453-61-8 |
Exemestane | EP/USP | Under R&D | 107868-30-4 |
Androgen | |||
Product Name | Specification | Approved | CAS No. |
Finasteride | CP/EP/USP | CEP/FDA/PMDA/GMP | 98319-26-7 |
Dutasteride | EP/USP | CEP/DMF | 164656-23-9 |
Abiraterone Acetate | CP/USP | DMF/WC | 154229-18-2 |
Testosterone | CP/EP/USP | CEP/DMF/WC | 58-22-0 |
Testosterone Undecanoate | CP | Under R&D | 5949-44-0 |
Testosterone Cypionate | USP | Under R&D | 58-20-8 |
DHEA(Prasterone) | FP/In-house | DMF/WC/Kosher | 53-43-0 |
Clascoterone | In-house | Under R&D | 19608-29-8 |
Cortical Hormone | |||
Product Name | Specification | Approved | CAS No. |
Budesonide | CP/EP/USP | CEP/FDA/GMP | 51333-22-3 |
Desonide | USP | DMF | 638-94-8 |
Eplerenone | EP | CEP/FDA | 107724-20-9 |
Methylprednisolone | CP/EP/USP | DMF/WC | 83-43-2 |
Methylprednisolone Hemisuccinate | CP/EP/USP | DMF/WC | 2921-57-5 |
Fluticasone Propionate | CP/EP/USP | DMF | 80474- 14-2 |
Fluticasone Furoate | In-house | Under R&D | 397864-44-7 |
Others | |||
Product Name | Specification | Approved | CAS No. |
Oxcarbazepine | CP/EP/USP | CEP/USDMF | 28721-07-5 |
Eslicarbazepine Acetate | In-house | DMF in process | 236395- 14-5 |
Ganciclovir | CP/EP/USP | DMF/GMP | 82410-32-0 |
Valganciclovir Hydrochloride | USP | DMF in process | 175865-59-5 |
Oseltamivir Phosphate | CP/EP/USP | DMF | 204255- 11-8 |
Baloxavir Marboxil | In-house | Under R&D | 1985606-14-1 |
Nintedanib Esylate | In-house | DMF | 656247-18-6 |
Revefenacin | In-house | DMF in process | 864750-70-9 |
Mirabegron | In-house | DMF | 223673-61-8 |
Escitalopram Oxalate | EP/USP/CP | DMF in process | 219861-08-2 |
Cariprazine Hydrochloride | In-house | DMF in process | 1083076-69-0 |
Lasmiditan Succinate | In-house | DMF in process | 439239-92-6 |
Luliconazole | In-house | DMF | 187164-19-8 |
Apalutamide | In-house | Under R&D | 956104-40-8 |
Tadalafil | EP/USP/CP | Under R&D | 171596-29-5 |
Relugolix | In-house | Under R&D | 737789-87-6 |
Phloroglucinol | CP | DMF | 108-73-6 |
Ursodeoxycholic Acid | EP/USP/JP | Under R&D | 128-13-2 |
Fluticasone furoate has In-house specifications. DMF under filing.
Mometasone furoate has CP、EP、USP specifications. DMF under filing.
Eslicarbazepine Acetate has In-house specification. DMF under filing.
Valganciclovir Hydrochloride has USP specification. DMF under filing.
Oseltamivir Phosphate has CP ,EP and USP specifications. DMF available.
Revefenacin has In-house specification. DMF under filing.